Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




National Comprehensive Cancer Network (NCCN) 13th Annual Conference
Link ID 3762
Title National Comprehensive Cancer Network (NCCN) 13th Annual Conference
Url http://www.medscape.com/viewprogram/8887?src=rss
Description Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Mar 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Exemestane May Improve Survival After Tamoxifen Therapy
  In women with early-stage, hormone receptor-positive breast cancer, extended therapy with the steroidal aromatase inhibitor exemestane after 5 years of treatment with tamoxifen significantly improves relapse-free survival, according to an analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 trial. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. Zoledronic Acid-Thalidomide Combination Does Not Increase Renal Risk
  Maintenance therapy with zoledronic acid and thalidomide in patients with multiple myeloma does not increase the risk of renal impairment, according to a report posted on March 31st by BMC Clinical Pharmacology. Reuters Health Information
Category:   Articles > Hematology-Oncology


3. HPV-Positive Throat Cancer Responds Better to Treatment
  The study also revealed that patients with tumors that express high levels of EGFR had the poorest survival rates. WebMD Health News
Category:   Articles > Hematology-Oncology


4. Improving the Quality of Life for Patients With PNH (Slides With Audio)
  Dr. Anita Hill, who specializes in paroxysmal nocturnal hemoglobinuria (PNH) and in marrow failure, discusses the effects on quality of life of new therapies.
Category:   Articles > Hematology-Oncology


5. International Approvals: Nexavar, Elaprase, Aranesp
  Europe has approved a new indication for sorafenib tosylate tablets (Nexavar) and an expanded indication for darbepoetin alfa (Aranesp); Japan has approved idursulfase solution (Elaprase). Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS